APA (7th ed.) Citation

M, A., RA, W., M, S., YH, W., TP, C., YR, L., . . . TL, H. (2025). Targeting Neutrophil-Mediated Inflammation: Identification of Pyrazolidinone Carboxamide Derivatives as Potent Selective Inhibitors of Formyl Peptide Receptor 1 (FPR1)-Activated Neutrophils. ACS pharmacology & translational science, 8(6), 1591. https://doi.org/10.1021/acsptsci.4c00715

Chicago Style (17th ed.) Citation

M, Abdel-Halim, et al. "Targeting Neutrophil-Mediated Inflammation: Identification of Pyrazolidinone Carboxamide Derivatives as Potent Selective Inhibitors of Formyl Peptide Receptor 1 (FPR1)-Activated Neutrophils." ACS Pharmacology & Translational Science 8, no. 6 (2025): 1591. https://doi.org/10.1021/acsptsci.4c00715.

MLA (9th ed.) Citation

M, Abdel-Halim, et al. "Targeting Neutrophil-Mediated Inflammation: Identification of Pyrazolidinone Carboxamide Derivatives as Potent Selective Inhibitors of Formyl Peptide Receptor 1 (FPR1)-Activated Neutrophils." ACS Pharmacology & Translational Science, vol. 8, no. 6, 2025, p. 1591, https://doi.org/10.1021/acsptsci.4c00715.